1. Home
  2. KVYO vs ICUI Comparison

KVYO vs ICUI Comparison

Compare KVYO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

N/A

Current Price

$21.07

Market Cap

4.9B

Sector

N/A

ML Signal

N/A

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

N/A

Current Price

$179.67

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVYO
ICUI
Founded
2012
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
KVYO
ICUI
Price
$21.07
$179.67
Analyst Decision
Strong Buy
Buy
Analyst Count
23
8
Target Price
$27.08
★ $194.25
AVG Volume (30 Days)
★ 4.8M
228.8K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
★ 100.62
EPS
N/A
★ 3.02
Revenue
$1,234,019,000.00
★ $2,231,262,000.00
Revenue This Year
$24.48
N/A
Revenue Next Year
$19.21
$4.27
P/E Ratio
$657.67
★ $57.37
Revenue Growth
★ 31.63
N/A
52 Week Low
$12.53
$113.37
52 Week High
$33.36
$192.85

Technical Indicators

Market Signals
Indicator
KVYO
ICUI
Relative Strength Index (RSI) 61.55 64.24
Support Level $15.09 $153.75
Resistance Level $21.24 $191.07
Average True Range (ATR) 1.03 7.20
MACD 0.01 1.39
Stochastic Oscillator 59.27 93.49

Price Performance

Historical Comparison
KVYO
ICUI

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: